ClinConnect ClinConnect Logo
Search / Trial NCT03839758

Study of Personalized Instrument in Total Shoulder Arthroplasty the P.I.T.S.A. Study

Launched by UNIVERSITÉ DE MONTRÉAL · Feb 13, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Prothesis Glenoid Implantation

ClinConnect Summary

The P.I.T.S.A. Study is researching a new way to help doctors perform shoulder surgery more accurately for patients suffering from shoulder arthritis. This study focuses on using a personalized guide, created from detailed 3D CT scans, to ensure the glenoid component (a part of the shoulder joint) is placed correctly during surgery. Proper placement is important because mistakes can lead to complications like pain, instability, or the need for more surgery later on. The goal is to see if this personalized guide can improve the surgery's success while also potentially reducing operating time and complications.

To participate in this study, you must be between 65 and 74 years old and have shoulder osteoarthritis or avascular necrosis (a condition where bone tissue dies due to a lack of blood supply). However, you won’t be eligible if you've had previous shoulder surgery, have inflammatory arthritis, or have had infections in your shoulder. If you join the study, you'll be monitored for two years after the surgery to evaluate how well the personalized guide works. This trial is currently recruiting participants, and it's a promising opportunity to help improve shoulder surgery outcomes for many patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with shoulder osteaoarthritis and AVN
  • Exclusion Criteria:
  • Patients with previous shoulder arthroplasty
  • Patients with inflammatory arthritis and tumor
  • Patients with previous shoulder surgery with metal implant
  • Patients refusing 2-year follow-up
  • Patients that does not speak English or French
  • Patients with current or previous shoulder infection
  • Patients with graft during surgery

About Université De Montréal

The Université de Montréal is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary research, the university engages in a wide range of clinical studies aimed at addressing pressing health challenges. Leveraging a robust network of expert faculty, state-of-the-art facilities, and a commitment to ethical standards, the Université de Montréal strives to enhance patient care and contribute to the global medical community through rigorous scientific inquiry and evidence-based practices.

Locations

Montréal, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Dominique Rouleau, MD

Principal Investigator

Université de Montréal

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials